Lacomax is prescribed for:
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Lacosamide's primary action is through the inhibition of sodium channels, which plays a role in reducing hyperexcitability of neurons. It's believed that Lacosamide selectively targets depolarized neurons (those with an abnormal resting potential) rather than those with normal potentials. The collapsin response mediator protein-2 (CRMP-2), which Lacosamide binds to, is involved in neuronal differentiation and axonal outgrowth, although its role in seizure control is still not fully understood.
Lacosamide's precise mechanism of action remains under study, but research suggests that it enhances the slow inactivation of voltage-gated sodium channels, stabilizing overexcited neurons and preventing repetitive neuronal firing.
For Partial-Onset Seizures (Monotherapy or Adjunctive Therapy) in Patients 1 Month and Older, and for Primary Generalized Tonic-Clonic Seizures (Adjunctive Therapy) in Patients 4 Years and Older:
Adults (≥17 years):
Pediatric Patients (≥50 kg):
Pediatric Patients (30-50 kg):
Pediatric Patients (6-30 kg):
Pediatric Patients (<6 kg):
Lacosamide tablets and oral solution can be taken with or without food.
No dose adjustment is needed for mild to moderate impairment; however, reduce dosage by 25% for severe renal impairment or end-stage renal disease.
Start at the lower end of the dosing range.
For mild to moderate hepatic impairment, reduce the dose by 25%. Lacosamide is not recommended for those with severe hepatic impairment.
Lacosamide is contraindicated for individuals with a known hypersensitivity to Lacosamide or any of its components.